Vital Images last week said it received 510(k) clearance fromthe Food and Drug Administration for its VoxelView 3-D workstation.VoxelView is based on a Silicon Graphics computer and employs3-D volume rendering and proprietary algorithms to give
Vital Images last week said it received 510(k) clearance fromthe Food and Drug Administration for its VoxelView 3-D workstation.VoxelView is based on a Silicon Graphics computer and employs3-D volume rendering and proprietary algorithms to give radiologistsand surgeons a noninvasive view of internal anatomy.
The Fairfield, IA, company made its first appearance at theRadiological Society of North America meeting last month, providingvisitors with virtual tours of nasal passages, colons and thecircle of Willis. Vital Images plans to market VoxelView on botha direct and indirect basis, according to Andrew Weiss, president.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.